ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Circular mRNA Drugs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-19X17563
Home | Market Reports | Science| Biological Sciences
Global Circular mRNA Drugs Market Research Report 2024
BUY CHAPTERS

Global Circular mRNA Drugs Market Research Report 2024

Code: QYRE-Auto-19X17563
Report
June 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Orna Therapeutics
Chimera Therapeutics
CirCode
Therorna Inc.
EdiGene Inc
Torque Bio
Sail Biomedicines
Orbital Therapeutics
Aikang Pharmaceuticals
Curemed Bio

Circular mRNA Drugs Market

In nature, circular RNA (circRNA) is ubiquitous in fungi, plants, insects, fish, and mammals, and even the genomes of some viruses are circular RNAs. Unlike linear mRNA, circular RNA is highly stable because its covalently closed ring structure protects it from exonuclease-mediated degradation. Therefore, vaccines based on circular mRNA have become a new vaccine option.
The global Circular mRNA Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Circular mRNA Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circular mRNA Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Circular mRNA Drugs include Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Circular mRNA Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circular mRNA Drugs.
The Circular mRNA Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Circular mRNA Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circular mRNA Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Circular mRNA Drugs Market Report

Report Metric Details
Report Name Circular mRNA Drugs Market
Segment by Type
  • Preventive Medicine
  • Medicine
Segment by Application
  • Infectious Disease
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Circular mRNA Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Circular mRNA Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Circular mRNA Drugs Market report?

Ans: The main players in the Circular mRNA Drugs Market are Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics

What are the Application segmentation covered in the Circular mRNA Drugs Market report?

Ans: The Applications covered in the Circular mRNA Drugs Market report are Infectious Disease, Cancer, Others

What are the Type segmentation covered in the Circular mRNA Drugs Market report?

Ans: The Types covered in the Circular mRNA Drugs Market report are Preventive Medicine, Medicine

1 Circular mRNA Drugs Market Overview
1.1 Product Definition
1.2 Circular mRNA Drugs by Type
1.2.1 Global Circular mRNA Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Circular mRNA Drugs by Application
1.3.1 Global Circular mRNA Drugs Market Value by Application (2024-2030)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Circular mRNA Drugs Market Size Estimates and Forecasts
1.4.1 Global Circular mRNA Drugs Revenue 2019-2030
1.4.2 Global Circular mRNA Drugs Sales 2019-2030
1.4.3 Global Circular mRNA Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Circular mRNA Drugs Market Competition by Manufacturers
2.1 Global Circular mRNA Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Circular mRNA Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Circular mRNA Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Circular mRNA Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Circular mRNA Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Circular mRNA Drugs, Product Type & Application
2.7 Global Key Manufacturers of Circular mRNA Drugs, Date of Enter into This Industry
2.8 Global Circular mRNA Drugs Market Competitive Situation and Trends
2.8.1 Global Circular mRNA Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Circular mRNA Drugs Players Market Share by Revenue
2.8.3 Global Circular mRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Circular mRNA Drugs Market Scenario by Region
3.1 Global Circular mRNA Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Circular mRNA Drugs Sales by Region: 2019-2030
3.2.1 Global Circular mRNA Drugs Sales by Region: 2019-2024
3.2.2 Global Circular mRNA Drugs Sales by Region: 2025-2030
3.3 Global Circular mRNA Drugs Revenue by Region: 2019-2030
3.3.1 Global Circular mRNA Drugs Revenue by Region: 2019-2024
3.3.2 Global Circular mRNA Drugs Revenue by Region: 2025-2030
3.4 North America Circular mRNA Drugs Market Facts & Figures by Country
3.4.1 North America Circular mRNA Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Circular mRNA Drugs Sales by Country (2019-2030)
3.4.3 North America Circular mRNA Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Circular mRNA Drugs Market Facts & Figures by Country
3.5.1 Europe Circular mRNA Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Circular mRNA Drugs Sales by Country (2019-2030)
3.5.3 Europe Circular mRNA Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Circular mRNA Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Circular mRNA Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Circular mRNA Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Circular mRNA Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Circular mRNA Drugs Market Facts & Figures by Country
3.7.1 Latin America Circular mRNA Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Circular mRNA Drugs Sales by Country (2019-2030)
3.7.3 Latin America Circular mRNA Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Circular mRNA Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Circular mRNA Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Circular mRNA Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Circular mRNA Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circular mRNA Drugs Sales by Type (2019-2030)
4.1.1 Global Circular mRNA Drugs Sales by Type (2019-2024)
4.1.2 Global Circular mRNA Drugs Sales by Type (2025-2030)
4.1.3 Global Circular mRNA Drugs Sales Market Share by Type (2019-2030)
4.2 Global Circular mRNA Drugs Revenue by Type (2019-2030)
4.2.1 Global Circular mRNA Drugs Revenue by Type (2019-2024)
4.2.2 Global Circular mRNA Drugs Revenue by Type (2025-2030)
4.2.3 Global Circular mRNA Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Circular mRNA Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Circular mRNA Drugs Sales by Application (2019-2030)
5.1.1 Global Circular mRNA Drugs Sales by Application (2019-2024)
5.1.2 Global Circular mRNA Drugs Sales by Application (2025-2030)
5.1.3 Global Circular mRNA Drugs Sales Market Share by Application (2019-2030)
5.2 Global Circular mRNA Drugs Revenue by Application (2019-2030)
5.2.1 Global Circular mRNA Drugs Revenue by Application (2019-2024)
5.2.2 Global Circular mRNA Drugs Revenue by Application (2025-2030)
5.2.3 Global Circular mRNA Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Circular mRNA Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Orna Therapeutics
6.1.1 Orna Therapeutics Company Information
6.1.2 Orna Therapeutics Description and Business Overview
6.1.3 Orna Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Orna Therapeutics Circular mRNA Drugs Product Portfolio
6.1.5 Orna Therapeutics Recent Developments/Updates
6.2 Chimera Therapeutics
6.2.1 Chimera Therapeutics Company Information
6.2.2 Chimera Therapeutics Description and Business Overview
6.2.3 Chimera Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chimera Therapeutics Circular mRNA Drugs Product Portfolio
6.2.5 Chimera Therapeutics Recent Developments/Updates
6.3 CirCode
6.3.1 CirCode Company Information
6.3.2 CirCode Description and Business Overview
6.3.3 CirCode Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CirCode Circular mRNA Drugs Product Portfolio
6.3.5 CirCode Recent Developments/Updates
6.4 Therorna
6.4.1 Therorna Company Information
6.4.2 Therorna Description and Business Overview
6.4.3 Therorna Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Therorna Circular mRNA Drugs Product Portfolio
6.4.5 Therorna Recent Developments/Updates
6.5 Edigene
6.5.1 Edigene Company Information
6.5.2 Edigene Description and Business Overview
6.5.3 Edigene Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Edigene Circular mRNA Drugs Product Portfolio
6.5.5 Edigene Recent Developments/Updates
6.6 Aikang Pharmaceuticals
6.6.1 Aikang Pharmaceuticals Company Information
6.6.2 Aikang Pharmaceuticals Description and Business Overview
6.6.3 Aikang Pharmaceuticals Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolio
6.6.5 Aikang Pharmaceuticals Recent Developments/Updates
6.7 Curemed Bio
6.7.1 Curemed Bio Company Information
6.7.2 Curemed Bio Description and Business Overview
6.7.3 Curemed Bio Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Curemed Bio Circular mRNA Drugs Product Portfolio
6.7.5 Curemed Bio Recent Developments/Updates
6.8 Torque Bio
6.8.1 Torque Bio Company Information
6.8.2 Torque Bio Description and Business Overview
6.8.3 Torque Bio Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Torque Bio Circular mRNA Drugs Product Portfolio
6.8.5 Torque Bio Recent Developments/Updates
6.9 Sail Biomedicines
6.9.1 Sail Biomedicines Company Information
6.9.2 Sail Biomedicines Description and Business Overview
6.9.3 Sail Biomedicines Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sail Biomedicines Circular mRNA Drugs Product Portfolio
6.9.5 Sail Biomedicines Recent Developments/Updates
6.10 Orbital Therapeutics
6.10.1 Orbital Therapeutics Company Information
6.10.2 Orbital Therapeutics Description and Business Overview
6.10.3 Orbital Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Orbital Therapeutics Circular mRNA Drugs Product Portfolio
6.10.5 Orbital Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circular mRNA Drugs Industry Chain Analysis
7.2 Circular mRNA Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circular mRNA Drugs Production Mode & Process
7.4 Circular mRNA Drugs Sales and Marketing
7.4.1 Circular mRNA Drugs Sales Channels
7.4.2 Circular mRNA Drugs Distributors
7.5 Circular mRNA Drugs Customers
8 Circular mRNA Drugs Market Dynamics
8.1 Circular mRNA Drugs Industry Trends
8.2 Circular mRNA Drugs Market Drivers
8.3 Circular mRNA Drugs Market Challenges
8.4 Circular mRNA Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Orna Therapeutics
Chimera Therapeutics
CirCode
Therorna Inc.
EdiGene Inc
Torque Bio
Sail Biomedicines
Orbital Therapeutics
Aikang Pharmaceuticals
Curemed Bio
List of Tables
 Table 1. Global Circular mRNA Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Circular mRNA Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Circular mRNA Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Circular mRNA Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Circular mRNA Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Circular mRNA Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Circular mRNA Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Circular mRNA Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Circular mRNA Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Circular mRNA Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Circular mRNA Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Circular mRNA Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Circular mRNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circular mRNA Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Circular mRNA Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Circular mRNA Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Circular mRNA Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Circular mRNA Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Circular mRNA Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Circular mRNA Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Circular mRNA Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Circular mRNA Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Circular mRNA Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Circular mRNA Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Circular mRNA Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Circular mRNA Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Circular mRNA Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Circular mRNA Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Circular mRNA Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Circular mRNA Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Circular mRNA Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Circular mRNA Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Circular mRNA Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Circular mRNA Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Circular mRNA Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Circular mRNA Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Circular mRNA Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Circular mRNA Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Circular mRNA Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Circular mRNA Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Circular mRNA Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Circular mRNA Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Circular mRNA Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Circular mRNA Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Circular mRNA Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Circular mRNA Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Circular mRNA Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Circular mRNA Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Circular mRNA Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Circular mRNA Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Circular mRNA Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Circular mRNA Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Circular mRNA Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Circular mRNA Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Circular mRNA Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Circular mRNA Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Circular mRNA Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Circular mRNA Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Circular mRNA Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Circular mRNA Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Circular mRNA Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Circular mRNA Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Circular mRNA Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Circular mRNA Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Circular mRNA Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Circular mRNA Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Circular mRNA Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Circular mRNA Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Orna Therapeutics Company Information
 Table 71. Orna Therapeutics Description and Business Overview
 Table 72. Orna Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Orna Therapeutics Circular mRNA Drugs Product
 Table 74. Orna Therapeutics Recent Developments/Updates
 Table 75. Chimera Therapeutics Company Information
 Table 76. Chimera Therapeutics Description and Business Overview
 Table 77. Chimera Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Chimera Therapeutics Circular mRNA Drugs Product
 Table 79. Chimera Therapeutics Recent Developments/Updates
 Table 80. CirCode Company Information
 Table 81. CirCode Description and Business Overview
 Table 82. CirCode Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. CirCode Circular mRNA Drugs Product
 Table 84. CirCode Recent Developments/Updates
 Table 85. Therorna Company Information
 Table 86. Therorna Description and Business Overview
 Table 87. Therorna Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Therorna Circular mRNA Drugs Product
 Table 89. Therorna Recent Developments/Updates
 Table 90. Edigene Company Information
 Table 91. Edigene Description and Business Overview
 Table 92. Edigene Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Edigene Circular mRNA Drugs Product
 Table 94. Edigene Recent Developments/Updates
 Table 95. Aikang Pharmaceuticals Company Information
 Table 96. Aikang Pharmaceuticals Description and Business Overview
 Table 97. Aikang Pharmaceuticals Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Aikang Pharmaceuticals Circular mRNA Drugs Product
 Table 99. Aikang Pharmaceuticals Recent Developments/Updates
 Table 100. Curemed Bio Company Information
 Table 101. Curemed Bio Description and Business Overview
 Table 102. Curemed Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Curemed Bio Circular mRNA Drugs Product
 Table 104. Curemed Bio Recent Developments/Updates
 Table 105. Torque Bio Company Information
 Table 106. Torque Bio Description and Business Overview
 Table 107. Torque Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Torque Bio Circular mRNA Drugs Product
 Table 109. Torque Bio Recent Developments/Updates
 Table 110. Sail Biomedicines Company Information
 Table 111. Sail Biomedicines Description and Business Overview
 Table 112. Sail Biomedicines Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Sail Biomedicines Circular mRNA Drugs Product
 Table 114. Sail Biomedicines Recent Developments/Updates
 Table 115. Orbital Therapeutics Company Information
 Table 116. Orbital Therapeutics Description and Business Overview
 Table 117. Orbital Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Orbital Therapeutics Circular mRNA Drugs Product
 Table 119. Orbital Therapeutics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Circular mRNA Drugs Distributors List
 Table 123. Circular mRNA Drugs Customers List
 Table 124. Circular mRNA Drugs Market Trends
 Table 125. Circular mRNA Drugs Market Drivers
 Table 126. Circular mRNA Drugs Market Challenges
 Table 127. Circular mRNA Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Circular mRNA Drugs
 Figure 2. Global Circular mRNA Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Circular mRNA Drugs Market Share by Type: 2023 & 2030
 Figure 4. Preventive Medicine Product Picture
 Figure 5. Medicine Product Picture
 Figure 6. Global Circular mRNA Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Circular mRNA Drugs Market Share by Application: 2023 & 2030
 Figure 8. Infectious Disease
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Circular mRNA Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Circular mRNA Drugs Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Circular mRNA Drugs Sales (2019-2030) & (K Units)
 Figure 14. Global Circular mRNA Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 15. Circular mRNA Drugs Report Years Considered
 Figure 16. Circular mRNA Drugs Sales Share by Manufacturers in 2023
 Figure 17. Global Circular mRNA Drugs Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Circular mRNA Drugs Players: Market Share by Revenue in Circular mRNA Drugs in 2023
 Figure 19. Circular mRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Circular mRNA Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Circular mRNA Drugs Sales Market Share by Country (2019-2030)
 Figure 22. North America Circular mRNA Drugs Revenue Market Share by Country (2019-2030)
 Figure 23. United States Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Circular mRNA Drugs Sales Market Share by Country (2019-2030)
 Figure 26. Europe Circular mRNA Drugs Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Circular mRNA Drugs Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Circular mRNA Drugs Revenue Market Share by Region (2019-2030)
 Figure 34. China Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Circular mRNA Drugs Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Circular mRNA Drugs Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Circular mRNA Drugs Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Circular mRNA Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Circular mRNA Drugs by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Circular mRNA Drugs by Type (2019-2030)
 Figure 53. Global Circular mRNA Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Circular mRNA Drugs by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Circular mRNA Drugs by Application (2019-2030)
 Figure 56. Global Circular mRNA Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 57. Circular mRNA Drugs Value Chain
 Figure 58. Circular mRNA Drugs Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Circular RNA Therapy Market Research Report 2024
Global circRNAs Treatment Market Research Report 2024
Global Circular RNA Research Market Insights Forecast to 2030
Global Circular RNA Drugs Market Research Report 2025
Global Exogenous Circular RNA Synthesis Service Market Research Report 2025
Global ircular RNA Synthesis Service Market Research Report 2024
Global CircRNA Synthesis Service Market Research Report 2024
Global Circular RNA Synthesis Kit Market Research Report 2024
Global Circular RNA Sequencing Market Insights Forecast to 2030
Global RNA Vaccines Market Insights Forecast to 2030
Global circRNA Technology Market Research Report 2024
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global RNA Stabilizers Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global circRNA LNP Formulation Market Research Report 2024
Global MicroRNA Market Research Report 2024
Global Self amplifying RNA saRNA Drugs Market Research Report 2024
Global miRNA Sequencing and Assay Market Insights Forecast to 2030
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions